(Q35189199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Uncommon opportunistic yeast bloodstream infections from Qatar (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Jacques F. Meis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

6

Teun Boekhout

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Saad J Taj-Aldeen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Atqah AbdulWahab

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Anand Deshmukh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

15 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

552-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24934803%20AND%20SRC:MED&resulttype=core&format=json

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Epidemiology of candidemia at a Children's hospital, 2002 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Epidemiological trends in nosocomial candidemia in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Cryptotrichosporon anacardii gen. nov., sp. nov., a new trichosporonoid capsulate basidiomycetous yeast from Nigeria that is able to form melanin on niger seed agar

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in h

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016

Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMYCOL%2FMYU016